Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03423992
Status:
UNKNOWN
Last Update Posted:
2021-06-15
First Post:
2018-01-22
Brief Title:
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrence Tumor |
| Glioma |
| Malignant Glioma of Brain |
Keywords: